These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 21514009

  • 21. Variants in TF and HFE explain approximately 40% of genetic variation in serum-transferrin levels.
    Benyamin B, McRae AF, Zhu G, Gordon S, Henders AK, Palotie A, Peltonen L, Martin NG, Montgomery GW, Whitfield JB, Visscher PM.
    Am J Hum Genet; 2009 Jan; 84(1):60-5. PubMed ID: 19084217
    [Abstract] [Full Text] [Related]

  • 22. Analysis of the hemochromatosis mutations C282Y and H63D in infertile men.
    Peterlin B, Kunej T, Hruskovicová H, Ferk P, Gersak K, Zorn B.
    Fertil Steril; 2006 Dec; 86(6):1796-8. PubMed ID: 17067586
    [Abstract] [Full Text] [Related]

  • 23. Evaluation of HFE (hemochromatosis) mutations as genetic modifiers in sporadic AD and MCI.
    Berlin D, Chong G, Chertkow H, Bergman H, Phillips NA, Schipper HM.
    Neurobiol Aging; 2004 Apr; 25(4):465-74. PubMed ID: 15013567
    [Abstract] [Full Text] [Related]

  • 24. Serum transferrin saturation increase is associated with decrease of antibacterial activity of serum in patients with HFE-related genetic hemochromatosis.
    Jolivet-Gougeon A, Loréal O, Ingels A, Danic B, Ropert M, Bardou-Jacquet E, Aqodad N, Aussant-Bertel F, Ferec C, Brissot P.
    Am J Gastroenterol; 2008 Oct; 103(10):2502-8. PubMed ID: 18684194
    [Abstract] [Full Text] [Related]

  • 25. The soluble transferrin receptor as a marker of iron homeostasis in normal subjects and in HFE-related hemochromatosis.
    Brandão M, Oliveira JC, Bravo F, Reis J, Garrido I, Porto G.
    Haematologica; 2005 Jan; 90(1):31-7. PubMed ID: 15642666
    [Abstract] [Full Text] [Related]

  • 26. The hepcidin gene promoter nc.-1010C > T; -582A > G haplotype modulates serum ferritin in individuals carrying the common H63D mutation in HFE gene.
    Silva B, Pita L, Gomes S, Gonçalves J, Faustino P.
    Ann Hematol; 2014 Dec; 93(12):2063-6. PubMed ID: 25015054
    [Abstract] [Full Text] [Related]

  • 27. Transferrin and HFE genes interact in Alzheimer's disease risk: the Epistasis Project.
    Lehmann DJ, Schuur M, Warden DR, Hammond N, Belbin O, Kölsch H, Lehmann MG, Wilcock GK, Brown K, Kehoe PG, Morris CM, Barker R, Coto E, Alvarez V, Deloukas P, Mateo I, Gwilliam R, Combarros O, Arias-Vásquez A, Aulchenko YS, Ikram MA, Breteler MM, van Duijn CM, Oulhaj A, Heun R, Cortina-Borja M, Morgan K, Robson K, Smith AD.
    Neurobiol Aging; 2012 Jan; 33(1):202.e1-13. PubMed ID: 20817350
    [Abstract] [Full Text] [Related]

  • 28. Screening selected blood donors with biochemical iron overload for hemochromatosis: a regional experience.
    De Gobbi M, D'Antico S, Castagno F, Testa D, Merlini R, Bondi A, Camaschella C.
    Haematologica; 2004 Oct; 89(10):1161-7. PubMed ID: 15477198
    [Abstract] [Full Text] [Related]

  • 29. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
    Zlocha J, Kovács L, Pozgayová S, Kupcová V, Durínová S.
    Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
    [Abstract] [Full Text] [Related]

  • 30. Failure to detect synergy between variants in transferrin and hemochromatosis and Alzheimer's disease in large cohort.
    Vance E, Gonzalez Murcia JD, Miller JB, Alzheimer's Disease Genetics Consortium (ADGC), Staley L, Crane PK, Mukherjee S, Kauwe JSK.
    Neurobiol Aging; 2020 May; 89():142.e9-142.e12. PubMed ID: 32143980
    [Abstract] [Full Text] [Related]

  • 31. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
    Walsh A, Dixon JL, Ramm GA, Hewett DG, Lincoln DJ, Anderson GJ, Subramaniam VN, Dodemaide J, Cavanaugh JA, Bassett ML, Powell LW.
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Variants in iron metabolism genes predict higher blood lead levels in young children.
    Hopkins MR, Ettinger AS, Hernández-Avila M, Schwartz J, Téllez-Rojo MM, Lamadrid-Figueroa H, Bellinger D, Hu H, Wright RO.
    Environ Health Perspect; 2008 Sep; 116(9):1261-6. PubMed ID: 18795173
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. HFE genotype and parameters of iron metabolism in German first-time blood donors - evidence for an increased transferrin saturation in C282Y heterozygotes.
    Raddatz D, Legler T, Lynen R, Addicks N, Ramadori G.
    Z Gastroenterol; 2003 Nov; 41(11):1069-76. PubMed ID: 14648375
    [Abstract] [Full Text] [Related]

  • 36. Iron, hemochromatosis genotypes, and risk of infections: a cohort study of 142 188 general population individuals.
    Mottelson M, Glenthøj A, Nordestgaard BG, Ellervik C, Petersen J, Bojesen SE, Helby J.
    Blood; 2024 Aug 15; 144(7):693-707. PubMed ID: 38728387
    [Abstract] [Full Text] [Related]

  • 37. Genetic screening for HFE hemochromatosis in 6,020 Danish men: penetrance of C282Y, H63D, and S65C variants.
    Pedersen P, Milman N.
    Ann Hematol; 2009 Aug 15; 88(8):775-84. PubMed ID: 19159930
    [Abstract] [Full Text] [Related]

  • 38. Mixture models of serum iron measures in population screening for hemochromatosis and iron overload.
    McLaren CE, Li KT, McLaren GD, Gordeuk VR, Snively BM, Reboussin DM, Barton JC, Acton RT, Dawkins FW, Harris EL, Eckfeldt JH, Moses GC, Adams PC.
    Transl Res; 2006 Oct 15; 148(4):196-206. PubMed ID: 17002922
    [Abstract] [Full Text] [Related]

  • 39. Gene-gene interactions among coding genes of iron-homeostasis proteins and APOE-alleles in cognitive impairment diseases.
    Tisato V, Zuliani G, Vigliano M, Longo G, Franchini E, Secchiero P, Zauli G, Paraboschi EM, Vikram Singh A, Serino ML, Ortolani B, Zurlo A, Bosi C, Greco A, Seripa D, Asselta R, Gemmati D.
    PLoS One; 2018 Oct 15; 13(3):e0193867. PubMed ID: 29518107
    [Abstract] [Full Text] [Related]

  • 40. HFE variants, APOE and Alzheimer's disease: findings from the population-based Rotterdam study.
    Alizadeh BZ, Njajou OT, Millán MR, Hofman A, Breteler MM, van Duijn CM.
    Neurobiol Aging; 2009 Feb 15; 30(2):330-2. PubMed ID: 17628213
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 16.